- Home
- UBX vs GENK Comparison
UBX vs GENK Comparison
Compare UBX & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- GENK
- Stock Information
- Founded
- UBX 2009
- GENK 2011
- Country
- UBX United States
- GENK United States
- Employees
- UBX N/A
- GENK N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- UBX Health Care
- GENK Consumer Discretionary
- Exchange
- UBX Nasdaq
- GENK Nasdaq
- Market Cap
- UBX 36.9M
- GENK 36.5M
- IPO Year
- UBX 2018
- GENK 2023
- Fundamental
- Price
- UBX $1.94
- GENK $5.51
- Analyst Decision
- UBX Strong Buy
- GENK Strong Buy
- Analyst Count
- UBX 2
- GENK 3
- Target Price
- UBX $7.00
- GENK $13.17
- AVG Volume (30 Days)
- UBX 203.3K
- GENK 65.2K
- Earning Date
- UBX 04-14-2025
- GENK 03-05-2025
- Dividend Yield
- UBX N/A
- GENK N/A
- EPS Growth
- UBX N/A
- GENK 483.78
- EPS
- UBX N/A
- GENK 0.17
- Revenue
- UBX N/A
- GENK $198,834,000.00
- Revenue This Year
- UBX N/A
- GENK $14.66
- Revenue Next Year
- UBX $33.62
- GENK $21.47
- P/E Ratio
- UBX N/A
- GENK $31.98
- Revenue Growth
- UBX N/A
- GENK 12.50
- 52 Week Low
- UBX $0.94
- GENK $5.26
- 52 Week High
- UBX $3.10
- GENK $14.46
- Technical
- Relative Strength Index (RSI)
- UBX 48.69
- GENK 31.30
- Support Level
- UBX $1.99
- GENK $5.26
- Resistance Level
- UBX $2.17
- GENK $5.73
- Average True Range (ATR)
- UBX 0.22
- GENK 0.35
- MACD
- UBX -0.05
- GENK 0.01
- Stochastic Oscillator
- UBX 22.41
- GENK 18.52
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.